13 results · 27ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

OPTMIZER CTS T-CELL EXPANSION SERUM FREE MEDIUM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

Plateau Spacer System

FDA UDI
Life Spine, Inc.·00190837045449·Barrel Shaver, 10mm

Plateau Spacer System

FDA UDI
Life Spine, Inc.·00190837045456·Barrel Sizer, 10mm

FORMATK MAGMA PLATFORM LASER

FDA Adverse Event
Injury ·FORMATK SYSTEMS LTD.·Product code GEX·December 19, 2019

VIBERECT PENILE VIBRATORY STIMULATION DEVICE

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

IMMULITE INTACT PTH, IMMULITE 2000 INTACT PTH, MODELS LKPP1 (100 TESTS), LKPP5 (500 TESTS), L2KPP2 (200 TESTS), L2KPP6

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

FORMATK MAGMA PLATFORM

FDA Adverse Event
Malfunction ·FOMATK SYSTEMS, LTD·Product code GEX·January 8, 2020

DEPUY ASR XL FEM IMP SIZE 53

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL·Product code KWA·May 15, 2013

COLIBRI

FDA Adverse Event
Malfunction ·SYNTHES GMBH·Product code HWE·September 24, 2014

3002 SECURE II

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FNL·May 24, 2011

BD INTIMA-II¿ CLOSED IV CATHETER SYSTEM

FDA Adverse Event
Malfunction ·BECTON DICKINSON MEDICAL DEVICES CO., LTD. SUZHOU·Product code FOZ·January 23, 2024

Quadra Assura MP, Sterile EO, Model #/ Part #: CD3269-40/100043177; CD3269-40Q/100043178; CD3271-40/100043130; CD3271-40Q/100043191; CD3369-40C/100080339, 100080478; CD3369-40Q/100080439, 100080476, 100105528; CD3371-40/100078814, 100079232, 100079513; CD3371-40C/100078639, 100079231, 100079478, 100105493, 100105494; CD3371-40Q/100078815,100079282, 100079479, 100138237; CD3371-40QC/100078640, 100079165, 100079506, 100079541, 100105505, 100105506, 100138173, 100138179, 100138222, 100138234; CD3387-40C/100105525; CD3387-40QC/100138158

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 4, 2018

INLIVEN CRT-P, Model Numbers: a) V284 b) V285 c) W274 d) W275 (added 7/15/2021)

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·July 21, 2021